natgillin/translations-raw huggingface dataset:
Preparation of endo-1,4-beta-xylanase (EC 3.2.1.8) and endo-1,3(4)-beta-glucanase (EC 3.2.1.6) produced by Talaromyces versatilis sp. nov. IMI CC 378536 and Talaromyces versatilis sp. nov. DSM 26702 having a minimum activity of:
Pripravak endo-1,4-beta-ksilanaze (EC 3.2.1.8) i endo-1,3(4)-beta-glukanaze (EC 3.2.1.6) dobiven od Talaromyces versatilis sp. nov. IMI CC 378536 i Talaromyces versatilis sp. nov. DSM 26702 najmanje aktivnosti od:
solid form: endo-1,4-beta-xylanase 22000 VU [1]/g and endo-1,3(4)-beta-glucanase 15200 VU/g;
kruti oblik: endo-1,4-beta-ksilanaza 22000 VJ [1]/g i endo-1,3(4)-beta-glukanaza 15200 VJ/g,
Endo-1,4-beta-xylanase (EC 3.2.1.8) and endo-1,3(4)-beta-glucanase (EC 3.2.1.6) produced by Talaromyces versatilis sp. nov. IMI CC 378536 and Talaromyces versatilis sp. nov. DSM 26702.
Endo-1,4-beta-ksilanaza (EC 3.2.1.8) i endo-1,3(4)-beta-glukanaza (EC 3.2.1.6) dobivene od Talaromyces versatilis sp. nov. IMI CC 378536 i Talaromyces versatilis sp. nov. DSM 26702.
Turkeys reared for breading
Purani uzgajani za rasplod
1 VU (viscosimetry unit) is the amount of enzyme which hydrolyses the substrate (barley betaglucan and wheat arabinoxylan, respectively), reducing the viscosity of the solution, to give a change in relative fluidity of 1 (dimensionless unit)/min at 30 °C and pH 5,5.
1 VJ (viskozimetrijska jedinica) količina je enzima koja hidrolizira supstrat (betaglukan ječma, odnosno arabinoksilan pšenice) i tako smanjuje viskoznost otopine, pri čemu nastaje promjena relativne fluidnosti od 1 (bezdimenzionalna jedinica)/min pri 30 °C i pH 5,5.
Commission Implementing Regulation (EU) 2015/2305
Provedbena uredba Komisije (EU) 2015/2305
concerning the authorisation of a preparation of endo-1,4-beta-glucanase (EC 3.2.1.4) produced by Trichoderma citrinoviride Bisset (IM SD142) as a feed additive for chickens for fattening, minor poultry species for fattening and weaned piglets, and amending Regulations (EC) No 2148/2004 and (EC) No 1520/2007 (holder of authorisation Huvepharma NV)
o odobrenju pripravka endo-1,4-beta-glukanaze (EC 3.2.1.4) dobivenog od Trichoderma citrinoviride Bisset (IM SD142) kao dodatka hrani za piliće za tov, manje značajne vrste peradi za tov i odbijenu prasad te o izmjeni uredaba (EZ) br. 2148/2004 i (EZ) br. 1520/2007 (nositelj odobrenja Huvepharma NV)
The preparation of endo-1,4-beta-glucanase (EC 3.2.1.4) produced by Trichoderma citrinoviride Bisset (IM SD142) (formerly Trichoderma longibrachiatum) hereinafter referred to as ‘the preparation specified in the Annex’ was authorised without a time limit in accordance with Directive 70/524/EEC as a feed additive for chickens for fattening by Commission Regulation (EC) No 2148/2004 [3] and for weaned piglets by Commission Regulation (EC) No 1520/2007 [4].
U skladu s Direktivom 70/524/EEZ pripravak endo-1,4-beta-glukanaze (EC 3.2.1.4) dobiven od Trichoderma citrinoviride Bisset (IM SD142) (bivši naziv Trichoderma longibrachiatum) (dalje u tekstu „pripravak naveden u Prilogu”) odobren je bez vremenskog ograničenja kao dodatak hrani za piliće za tov Uredbom Komisije (EZ) br. 2148/2004 [3] te za odbijenu prasad Uredbom Komisije (EZ) br. 1520/2007 [4].
In accordance with Article 10(2) of Regulation (EC) No 1831/2003 in conjunction with Article 7 of that Regulation, an application was submitted for the re-evaluation of the preparation of endo-1,4-beta-glucanase (EC 3.2.1.4) produced by Trichoderma citrinoviride Bisset (IM SD142) (formerly Trichoderma longibrachiatum) as a feed additive for chickens for fattening, minor poultry species for fattening and weaned piglets.
U skladu s člankom 10. stavkom 2. Uredbe (EZ) br. 1831/2003 u vezi s člankom 7. te Uredbe podnesen je zahtjev za ponovnu procjenu pripravka endo-1,4-betaglukanaze (EC 3.2.1.4) dobivenog od Trichoderma citrinoviride Bisset (IM SD142) (bivši naziv Trichoderma longibrachiatum) kao dodatka hrani za piliće za tov, manje značajne vrste peradi za tov i odbijenu prasad.
The applicant requested that additive to be classified in the additive category ‘zootechnical additives’.
Podnositelj zahtjeva zatražio je da se taj dodatak razvrsta u kategoriju dodataka „zootehnički dodaci”.
The European Food Safety Authority (‘the Authority’) concluded in its opinions of 17 April 2013 [5] and 10 March 2015 [6] that, under the proposed conditions of use, the preparation of endo-1,4-beta-glucanase (EC 3.2.1.4) produced by Trichoderma citrinoviride Bisset (IM SD142) (formerly Trichoderma longibrachiatum) does not have an adverse effect on animal health, human health or the environment.
Europska agencija za sigurnost hrane („Agencija”) u svojim je mišljenjima od 17. travnja 2013. [5] i 10. ožujka 2015.
The Authority also concluded that the use of that preparation has the potential to be efficacious in chickens for fattening and weaned piglets.
zaključila da pripravak endo-1,4-beta-glukanaze (EC 3.2.1.4) dobiven od Trichoderma citrinoviride Bisset (IM SD142) (bivši naziv Trichoderma longibrachiatum) u predloženim uvjetima uporabe nema negativan učinak na zdravlje životinja, zdravlje ljudi ili na okoliš.
The Authority further considered that the conclusions on the efficacy can be extrapolated to minor poultry species for fattening.
Agencija je zaključila i da uporaba tog pripravka može biti učinkovita kod pilića za tov i odbijene prasadi. Stav je Agencije i da se zaključci o učinkovitosti mogu primijeniti na manje značajne vrste peradi za tov.
It does not consider that there is a need for specific requirements of post-market monitoring.
Agencija smatra da ne postoji potreba za posebnim zahtjevima za praćenje nakon stavljanja na tržište.
The assessment of the preparation of endo-1,4-beta-glucanase (EC 3.2.1.4) produced by Trichoderma citrinoviride Bisset (IM SD142) (formerly Trichoderma longibrachiatum) shows that the conditions for authorisation, as provided for in Article 5 of Regulation (EC) No 1831/2003, are satisfied.
Ocjenom pripravka endo-1,4-beta-glukanaze (EC 3.2.1.4) dobivenog od Trichoderma citrinoviride Bisset (IM SD142) (bivši naziv Trichoderma longibrachiatum) utvrđeno je da su ispunjeni uvjeti za odobrenje propisani člankom 5. Uredbe (EZ) br. 1831/2003.
Regulations (EC) No 2148/2004 and (EC) No 1520/2007 should be amended accordingly.
Uredbe (EZ) br. 2148/2004 i (EZ) br. 1520/2007 trebalo bi stoga na odgovarajući način izmijeniti.
In Annex IV to Regulation (EC) No 2148/2004 the entry on E 1616, endo-1,4-beta-glucanase, is deleted.
U Prilogu IV. Uredbi (EZ) br. 2148/2004 briše se unos o E 1616, endo-1,4-beta-glukanazi.
Amendment to Regulation (EC) No 1520/2007
Izmjena Uredbe (EZ) br. 1520/2007
Regulation (EC) No 1520/2007 is amended as follows:
Uredba (EZ) br. 1520/2007 mijenja se kako slijedi: 1. Članak 5. briše se.
The preparation specified in the Annex, and feed containing that preparation, which is produced and labelled before 30 June 2016 in accordance with the rules applicable before 31 December 2015 may continue to be placed on the market and used until the existing stocks are exhausted.
Pripravak naveden u Prilogu i hrana za životinje koja taj pripravak sadržava, a koji su proizvedeni i označeni prije 30. lipnja 2016. u skladu s pravilima primjenjivima prije 31. prosinca 2015., mogu se nastaviti stavljati na tržište i upotrebljavati dok se ne potroše postojeće zalihe.
Commission Regulation (EC) No 1520/2007 of 19 December 2007 concerning the permanent authorisations of certain additives in feedingstuffs (OJ L 335, 20.12.2007, p. 17).
Uredba Komisije (EZ) br. 1520/2007 od 19. prosinca 2007. o trajnom odobrenju određenih dodataka hrani za životinje (SL L 335, 20.12.2007., str. 17.).
EFSA Journal 2013; 11(7):3207.
EFSA Journal 2013.; 11(7):3207.
EFSA Journal 2015; 13(3):4054.
EFSA Journal 2015.; 13(3):4054.
Endo-1,4-beta-glucanase
Huvepharma NV
EC 3.2.1.4
Endo-1,4-beta-glukanaza EC 3.2.1.4
Additive composition:
Sastav dodatka hrani za životinje
Preparation of endo-1,4-beta-glucanase (EC 3.2.1.4) produced by Trichoderma citrinoviride Bisset (IM SD142) with a minimum activity of 2000 CU [1]/g (solid and liquid form).
Pripravak endo-1,4-beta-glukanaze (EC 3.2.1.4) dobiven od Trichoderma citrinoviride Bisset (IM SD142) najmanje aktivnosti od 2000 CU [1]/g (kruti i tekući oblik).
Endo-1,4-beta-glucanase (EC 3.2.1.4) produced by Trichoderma citrinoviride Bisset (IM SD142).
Endo-1,4-beta-glukanaza (EC 3.2.1.4) dobivena od Trichoderma citrinoviride Bisset (IM SD142).
Analytical method [2]: For the determination of endo-1,4-beta-glucanase in feed additive, premixtures and feedingstuffs:
Analitička metoda [2]Za određivanje endo-1,4-beta-glukanaze u dodatku hrani za životinje, premiksima i hrani za životinje:
colorimetric method based on the quantification of water soluble dyed fragments (azurine) produced by the action of endo-1,4-beta-glucanase on azurine-crosslinked cellulose.
kolorimetrijska metoda koja se temelji na kvantifikaciji obojenih fragmenata topljivih u vodi (azurin) dobivenih djelovanjem endo-1,4-beta-glukanaze na celulozu križno vezanu na azurin.
Chickens for fattening and minor poultry species for fattening
Pilići za tov i manje značajne vrste peradi za tov
1 CU is the amount of enzyme that liberates 0,128 micromoles of reducing sugars (glucose equivalents) from barley beta-glucan per minute at pH 4,5 and 30 °C.
CU količina je enzima koja oslobađa 0,128 mikromola reducirajućih šećera (ekvivalenti glukoze) iz beta-glukana ječma po minuti pri pH 4,5 i 30 °C.
Article 5 is deleted; (2) Annex V is deleted.
2. Prilog V. briše se.
Commission Implementing Regulation (EU) 2015/2306
Provedbena uredba Komisije (EU) 2015/2306
concerning the authorisation of L-cysteine hydrochloride monohydrate as a feed additive for cats and dogs
u pogledu odobrenja L-cistein hidroklorid monohidrata kao dodatka hrani za mačke i pse
L-cysteine hydrochloride monohydrate was authorised without a time limit in accordance with Directive 70/524/EEC as a feed additive for all animal species.
U skladu s Direktivom 70/524/EEZ L-cistein hidroklorid monohidrat odobren je bez vremenskog ograničenja kao dodatak hrani za sve životinjske vrste.
In accordance with Article 10(2) of Regulation (EC) No 1831/2003 in conjunction with Article 7 thereof, an application was submitted for the re-evaluation of L-cysteine hydrochloride monohydrate as a feed additive for cats and dogs.
U skladu s člankom 10. stavkom 2. Uredbe (EZ) br. 1831/2003 u vezi s njezinim člankom 7. podnesen je zahtjev za ponovnu ocjenu L-cistein hidroklorid monohidrata kao dodatka hrani za mačke i pse.
The applicant requested that additive be classified in the additive category ‘sensory additives’.
Podnositelj zahtjeva zatražio je da se taj dodatak razvrsta u kategoriju dodataka „osjetilni dodaci”.
The European Food Safety Authority (‘the Authority’) concluded in its opinion of 10 October 2013 [3] that, under the proposed conditions of use in feed, L-cysteine hydrochloride monohydrate does not have adverse effects on animal health, human health or the environment.
Europska agencija za sigurnost hrane (dalje u tekstu: „Agencija”) u svojem je mišljenju od 10. listopada 2013. [3] zaključila da L-cistein hidroklorid monohidrat u predloženim uvjetima upotrebe u hrani za životinje nema negativan učinak na zdravlje životinja, zdravlje ljudi ili na okoliš.
The Authority further stated that L-cystine and L-cysteine hydrochloride are flavouring agents authorised in food for which the efficacy is demonstrated although it is not clear that L-cysteine hydrochloride monohydrate is used as a flavouring in pet food in the same way as it is used in food.
Agencija je dodala da su L-cistin i L-cistein hidroklorid arome odobrene za upotrebu u hrani čija je učinkovitost dokazana, međutim nije jasno upotrebljava li se L-cistein hidroklorid monohidrat kao aroma u hrani za kućne ljubimce na način na koji se upotrebljava u hrani.
Considering the evidence provided by the applicant, the Authority also concluded that the efficacy of L-cysteine hydrochloride monohydrate with respect to the final concentration in feed cannot be assessed.
Uzimajući u obzir dokaze koje je dostavio podnositelj zahtjeva, Agencija je zaključila i da se učinkovitost L-cistein hidroklorid monohidrata u pogledu konačne koncentracije u hrani za životinje ne može procijeniti.
However, the Authority also stated that this additive is authorised in food and, where the function for feed is essentially the same as that for food, no further demonstration of efficacy is necessary.
Međutim, Agencija je izjavila i da je taj dodatak odobren za upotrebu u hrani te stoga nisu potrebni dodatni dokazi o njegovoj djelotvornosti kada je njegova funkcija u hrani za životinje jednaka kao u hrani.
Considering further evidence provided by the applicant the Commission concluded that, although L-cysteine hydrochloride monohydrate relates to a different chemical structure with respect to L-cystine and L-cysteine hydrochloride, the fact that the additive is monohydrated does not change its efficacy.
Uzimajući u obzir dodatne dokaze koje je dostavio podnositelj zahtjeva, Komisija je zaključila da, iako L-cistein hidroklorid monohidrat ima drugačiju kemijsku strukturu u usporedbi s L-cistinom i L-cistein hidrokloriod, činjenica da je taj dodatak monohidrat ne utječe na njegovu učinkovitost.
The Commission also concluded that use levels for this additive are higher to the normal and maximum use levels reported in food for different types of products, therefore, there is sufficient evidence of the efficacy of this substance.
Komisija je također zaključila da su razine upotrebe tog aditiva veće od uobičajenih i najvećih razina upotrebe u hrani za različite vrste proizvoda te da stoga postoji dovoljno dokaza za djelotvornost te tvari.
The Authority concluded that no safety concerns would arise for users provided that appropriate protective measures are taken.
Agencija je zaključila da neće doći do sigurnosnih rizika za potrošače ako se poduzmu odgovarajuće mjere zaštite.
The assessment of L-cysteine hydrochloride monohydrate shows that the conditions for authorisation, as provided for in Article 5 of Regulation (EC) No 1831/2003, are satisfied.
Ocjenom L-cistein hidroklorid monohidrata utvrdilo se da su ispunjeni uvjeti za odobrenje predviđeni člankom 5. Uredbe (EZ) br. 1831/2003.
Accordingly, the use of L-cysteine hydrochloride monohydrate should be authorised as specified in the Annex to this Regulation.
U skladu s tim trebalo bi odobriti upotrebu L-cistein hidroklorid monohidrata kako je naveden u Prilogu ovoj Uredbi.
Since safety reasons do not require the immediate application of the modifications to the conditions of authorisation for L-cysteine hydrochloride monohydrate it is appropriate to allow a transitional period for interested parties to prepare themselves to meet the new requirements resulting from the authorisation.
Budući da ne postoje sigurnosni razlozi zbog kojih bi izmjene uvjeta izdavanja odobrenja za L-cistein hidroklorid monohidrat bilo potrebno odmah primjenjivati, primjereno je zainteresiranim stranama omogućiti prijelazno razdoblje kako bi se pripremile za ispunjavanje novih zahtjeva koji proizlaze iz odobrenja.
The substance specified in the Annex, belonging to the additive category ‘sensory additives’ and to the functional group ‘flavouring compounds’, is authorised as a feed additive in animal nutrition subject to the conditions laid down in that Annex.
Tvar navedena u Prilogu, koja pripada kategoriji dodataka hrani za životinje „osjetilni dodaci” i funkcionalnoj skupini „aromatske tvari”, odobrava se kao dodatak hrani za životinje pod uvjetima utvrđenima u tom Prilogu.
Transitional Measures
Prijelazne mjere
The substance specified in the Annex and premixtures containing this substance, which are produced and labelled before 30 June 2016 in accordance with the rules applicable before 31 December 2015 may continue to be placed on the market and used until the existing stocks are exhausted.
Tvar navedena u Prilogu i premiksi koji tu tvar sadržavaju, a koji su proizvedeni i označeni prije 30. lipnja 2016. u skladu s pravilima primjenjivima prije 31. prosinca 2015., mogu se nastaviti stavljati na tržište i upotrebljavati dok se ne potroše postojeće zalihe.
Compound feed and feed materials containing the substance specified in the Annex which are produced and labelled before 31 December 2017 in accordance with the rules applicable before 31 December 2015 may continue to be placed on the market and used until the existing stocks are exhausted.
Hrana za kućne ljubimce i krmiva koji sadržavaju tvar navedenu u Prilogu, a koji su proizvedeni i označeni prije 31. prosinca 2017. u skladu s pravilima primjenjivima prije 31. prosinca 2015., mogu se nastaviti stavljati na tržište i upotrebljavati dok se ne potroše postojeće zalihe.
EFSA Journal 2013;11(10):3437
EFSA Journal 2013.;11(10):3437
mg of active substance/kg of complete feedingstuff with a moisture content of 12 %.
mg aktivne tvari po kg potpune krmne smjese s udjelom vlage od 12 %
Category: Sensory additives.
Kategorija: osjetilni dodaci.
Functional group: Flavouring compounds.
Funkcionalna skupina: aromatske tvari.
L-cysteine hydrochloride monohydrate
L-cistein hidroklorid monohidrat
L-cysteine hydrochloride monohydrate.
L-cistein hidroklorid monohidrat
CAS No: 7048-04-6
CAS br.: 7048-04-6
L-cysteine hydrochloride monohydrate solid form, produced by hydrolysis of keratin from avian feathers.
L-cistein hidroklorid monohidrat u krutom stanju, proizveden hidrolizom keratina iz ptičjeg perja.
Purity: min. 98,5 % assay.
Čistoća: najmanje 98,5 % sadržaja.
Method of analysis [1]For the quantification of L-cysteine hydrochloride monohydrate in feed additive: titrimetry, European Pharmacopoeia (Ph. Eur. 6,0, method 01/2008:0895).
Metoda analize [1]Za kvantifikaciju L-cistein hidroklorid monohidrata u dodatku hrani za životinje: titrimetrija, Europska farmakopeja (Ph. Eur. 6.0, metoda 01/2008:0895).
For the quantification of Cyst(e)ine (including L-cysteine hydrochloride monohydrate) in premixtures and feedingstuffs: ion exchange chromatography method with post-column derivatisation and photometric detection: Commission Regulation (EC) No 152/2009 [2] (Annex III, F).
Za kvantifikaciju cist(e)ina (uključujući L-cistein hidroklorid monohidrat) u premiksima i krmnim smjesama:: metoda kromatografije izmjene iona s postkolonskom derivatizacijom i fotometrijskim otkrivanjem: Uredba Komisije (EZ) br. 152/2009 [2] (Prilog III., F).
Indicate in the directions for use of the additive and premixture:
U uputama za upotrebu dodatka i premiksa potrebno je navesti sljedeće:
the storage conditions;
uvjete pohrane,
supplementation with L-cysteine hydrochloride monohydrate shall depend on the requirements of cats and dogs for sulphur-containing amino acids and the level of other sulphur-containing amino acids in the ration.
dodavanje L-cistein hidroklorid monohidrata ovisi o potrebama mačaka i pasa za aminokiselinama koje sadržavaju sumpor te o razini drugih aminokiselina koje sadržavaju sumpor u dozi.
For safety: breathing protection, safety glasses and gloves shall be worn during handling.
Radi sigurnosti pri rukovanju se nosi zaštita za dišne organe, zaštitne naočale i rukavice.
Commission Regulation (EC) No 152/2009 of 27 January 2009 laying down the methods of sampling and analysis for the official control of feed (OJ L 54, 26.2.2009, p. 1).
Uredba Komisije (EZ) br. 152/2009 od 27. siječnja 2009. o utvrđivanju metoda uzorkovanja i analize za službenu kontrolu hrane za životinje (SL L 54, 26.2.2009., str.1.).
Commission Implementing Regulation (EU) 2015/2307
Provedbena uredba Komisije (EU) 2015/2307
concerning the authorisation of menadione sodium bisulphite and menadione nicotinamide bisulphite as feed additives for all animal species
o odobrenju menadion natrijeva bisulfita i menadion nikotinamid bisulfita kao dodataka hrani za sve životinjske vrste
Vitamin K was authorised without a time limit in accordance with Directive 70/524/EEC as feed additive for all animal species.
U skladu s Direktivom 70/524/EEZ vitamin K odobren je bez vremenskog ograničenja kao dodatak hrani za sve životinjske vrste.
In accordance with Article 10(2) of Regulation (EC) No 1831/2003 in conjunction with Article 7 thereof, an application was submitted for the re-evaluation of the use of vitamin K3 in the form of menadione sodium bisulphite and menadione nicotinamide bisulphite as feed additives for all animal species.
U skladu s člankom 10. stavkom 2. Uredbe (EZ) br. 1831/2003 u vezi s njezinim člankom 7. podnesen je zahtjev za ponovnu ocjenu upotrebe vitamina K3 u obliku menadion natrijeva bisulfita i menadion nikotinamid bisulfita kao dodataka hrani za sve životinjske vrste.
The applicant requested that these additives be classified in the additive category ‘nutritional additives’.
Podnositelj zahtjeva zatražio je da se ti dodaci razvrstaju u kategoriju dodataka „nutritivni dodaci”.
The European Food Safety Authority (‘the Authority’) concluded in its opinion of 16 January 2014 [3] that, under the proposed conditions of use in feed, menadione sodium bisulphite and menadione nicotinamide bisulphite do not have adverse effects on animal health, human health or the environment.
Europska agencija za sigurnost hrane (dalje u tekstu: „Agencija”) u svojem je mišljenju od 16. siječnja 2014. [3] zaključila da menadion natrijev bisulfit i menadion nikotinamid bisulfit u predloženim uvjetima upotrebe u hrani za životinje nemaju negativan učinak na zdravlje životinja, zdravlje ljudi ili na okoliš.
The Authority further concluded that menadione sodium bisulphite and menadione nicotinamide bisulphite are effective sources of vitamin K and that no safety concerns would arise for users provided that appropriate protective measures are taken.
Agencija je zaključila i da su menadion natrijev bisulfit i menadion nikotinamid bisulfit učinkoviti izvori vitamina K. te da neće doći do sigurnosnih rizika za potrošače ako se poduzmu odgovarajuće zaštitne mjere.
The assessment of menadione sodium bisulphite and menadione nicotinamide bisulphite shows that the conditions for authorisation, as provided for in Article 5 of Regulation (EC) No 1831/2003, are satisfied.
Ocjenom menadion natrijeva bisulfita i menadion nikotinamid bisulfita utvrdilo se da su ispunjeni uvjeti za odobrenje predviđeni člankom 5. Uredbe (EZ) br. 1831/2003.
Accordingly, the use of menadione sodium bisulphite and menadione nicotinamide bisulphite should be authorised as specified in the Annex to this Regulation.
U skladu s tim trebalo bi odobriti upotrebu menadion natrijeva bisulfita i menadion nikotinamid bisulfita kako su navedeni u Prilogu ovoj Uredbi.
Although the applicant withdrew the application for the use of menadione sodium bisulphite in water for drinking, this additive can be used within a compound feed subsequently administered via water.
Iako je podnositelj zahtjeva povukao zahtjev za upotrebu menadion natrijeva bisulfita u vodi za piće, taj se dodatak može upotrebljavati u krmnim smjesama koje se potom primjenjuju putem vode.
Since safety reasons do not require the immediate application of the modifications to the conditions of authorisation for menadione sodium bisulphite and menadione nicotinamide bisulphite, it is appropriate to allow a transitional period for interested parties to prepare themselves to meet the new requirements resulting from the authorisation.
Budući da ne postoje sigurnosni razlozi zbog kojih bi izmjene uvjeta izdavanja odobrenja za menadion natrijev bisulfit i menadion nikotinamid bisulfit bilo potrebno odmah primjenjivati, primjereno je zainteresiranim stranama omogućiti prijelazno razdoblje kako bi se pripremile za ispunjavanje novih zahtjeva koji proizlaze iz odobrenja.
The substances specified in the Annex and premixtures containing these substances, which are produced and labelled before 30 June 2016 in accordance with the rules applicable before 31 December 2015 may continue to be placed on the market and used until the existing stocks are exhausted.
Tvari navedene u Prilogu i premiksi koji te tvari sadržavaju, koji su proizvedeni i označeni prije 30. lipnja 2016. u skladu s pravilima primjenjivima prije 31. prosinca 2015., mogu se nastaviti stavljati na tržište i upotrebljavati dok se ne potroše postojeće zalihe.